Good to be back Senderos. The more things change the more things stay the same. Difficult amount of dilution over the years. It does look like Nasrat has a winner in Adderall IR/ER though. Let's hope revenue outstrips the ongoing dilution. And here's to hoping Nasrat sells Elite Mikah's 50% of Adderall for future revenue sails as opposed to more ELTP shares.